Skip to main content
Erschienen in: Journal of Diabetes & Metabolic Disorders 1/2018

29.03.2018 | Research Article

Acute phase ketosis-prone atypical diabetes is associated with a pro-inflammatory profile: a case-control study in a sub-Saharan African population

verfasst von: Eric Lontchi-Yimagou, Philippe Boudou, Jean Louis Nguewa, Jean Jacques Noubiap, Vicky Kamwa, Eric Noel Djahmeni, Babara Atogho-Tiedeu, Marcel Azabji-Kenfack, Martine Etoa, Gaelle Lemdjo, Mesmin Yefou Dehayem, Jean Claude Mbanya, Jean-Francois Gautier, Eugène Sobngwi

Erschienen in: Journal of Diabetes & Metabolic Disorders | Ausgabe 1/2018

Einloggen, um Zugang zu erhalten

Abstract

Background

It is unknown whether inflammation plays a role in metabolic dysfunction on ketosis-prone diabetes (KPD). We aimed to assess the inflammatory profile in sub-Saharan African patients with KPD during the acute ketotic phase as well as during non-ketotic hyperglycemic crises.

Methods

We studied 72 patients with non-autoimmune diabetes: 23 with type 2 diabetes mellitus (T2D), and 49 with KPD, all admitted in hyperglycemic crisis (plasma glucose ≥250 mg/dl). The T2D and KPD groups were matched by sex, age, and Body Mass Index. KPD was sub-classified into new-onset ketotic phase (n = 34) or non-ketotic phase (n = 15). We measured TNF-α, MCP-1, MIP1-α, IL-8, MIP1-β, and VEGF in the serum of all participants.

Results

TNF-α and IL-8 were higher in participants with KPD compared to those with T2D (p = 0.02 TNF-α; p = 0.03 IL-8). TNF-α and IL-8 were also higher in the ketotic phase KPD group compared to the T2D group (p = 0.03 TNF-α; p < 0.001 IL-8) while MIP1-α was lower in people with ketotic phase KPD compared to their T2D counterparts (p = 0.03). MIP1-α was lower in the ketotic phase KPD group compared to the non-ketotic phase KPD group (p = 0.04). MCP-1 was lower in non-ketotic phase KPD compared to T2D (p = 0.04), and IL-8 was higher in non-ketotic phase KPD compared to T2D (p = 0.02).

Conclusions

Participants with KPD had elevated pro-inflammatory cytokines compared to their T2D counterparts. Ketotic phase KPD is associated with a different pro-inflammatory profile compared to non-ketotic phase KPD, and the inflammatory profile appears to be comparable between non-ketotic phase KPD and T2D patients.
Literatur
1.
Zurück zum Zitat Leahy JL, Hirsch IB, Peterson KA, Schneider D. Targeting beta-cell function early in the course of therapy for type 2 diabetes mellitus. J Clin Endocrinol Metab. 2010;95(9):4206–16.CrossRefPubMed Leahy JL, Hirsch IB, Peterson KA, Schneider D. Targeting beta-cell function early in the course of therapy for type 2 diabetes mellitus. J Clin Endocrinol Metab. 2010;95(9):4206–16.CrossRefPubMed
2.
Zurück zum Zitat Dobrian AD, Galkina EV, Ma Q, Hatcher M, Aye SM, Butcher MJ, et al. STAT4 deficiency reduces obesity-induced insulin resistance and adipose tissue inflammation. Diabetes. 2013;62(12):4109–21.CrossRefPubMedPubMedCentral Dobrian AD, Galkina EV, Ma Q, Hatcher M, Aye SM, Butcher MJ, et al. STAT4 deficiency reduces obesity-induced insulin resistance and adipose tissue inflammation. Diabetes. 2013;62(12):4109–21.CrossRefPubMedPubMedCentral
3.
Zurück zum Zitat Kiely A, McClenaghan NH, Flatt PR, Newsholme P. Pro-inflammatory cytokines increase glucose, alanine and triacylglycerol utilization but inhibit insulin secretion in a clonal pancreatic beta-cell line. J Endocrinol. 2007;195(1):113–23.CrossRefPubMed Kiely A, McClenaghan NH, Flatt PR, Newsholme P. Pro-inflammatory cytokines increase glucose, alanine and triacylglycerol utilization but inhibit insulin secretion in a clonal pancreatic beta-cell line. J Endocrinol. 2007;195(1):113–23.CrossRefPubMed
4.
Zurück zum Zitat Souza KL, Gurgul-Convey E, Elsner M, Lenzen S. Interaction between pro-inflammatory and anti-inflammatory cytokines in insulin-producing cells. J Endocrinol. 2008;197(1):139–50.CrossRefPubMed Souza KL, Gurgul-Convey E, Elsner M, Lenzen S. Interaction between pro-inflammatory and anti-inflammatory cytokines in insulin-producing cells. J Endocrinol. 2008;197(1):139–50.CrossRefPubMed
5.
Zurück zum Zitat Lontchi-Yimagou E, Sobngwi E, Matsha TE, Kengne AP. Diabetes mellitus and inflammation. Curr Diab Rep. 2013;13(3):435–44.CrossRefPubMed Lontchi-Yimagou E, Sobngwi E, Matsha TE, Kengne AP. Diabetes mellitus and inflammation. Curr Diab Rep. 2013;13(3):435–44.CrossRefPubMed
6.
Zurück zum Zitat Menart-Houtermans B, Rutter R, Nowotny B, Rosenbauer J, Koliaki C, Kahl S, et al. Leukocyte profiles differ between type 1 and type 2 diabetes and are associated with metabolic phenotypes: results from the German diabetes study (GDS). Diabetes Care. 2014;37(8):2326–33.CrossRefPubMed Menart-Houtermans B, Rutter R, Nowotny B, Rosenbauer J, Koliaki C, Kahl S, et al. Leukocyte profiles differ between type 1 and type 2 diabetes and are associated with metabolic phenotypes: results from the German diabetes study (GDS). Diabetes Care. 2014;37(8):2326–33.CrossRefPubMed
7.
Zurück zum Zitat DeFuria J, Belkina AC, Jagannathan-Bogdan M, Snyder-Cappione J, Carr JD, Nersesova YR, et al. B cells promote inflammation in obesity and type 2 diabetes through regulation of T-cell function and an inflammatory cytokine profile. Proc Natl Acad Sci U S A. 2013;110(13):5133–8.CrossRefPubMedPubMedCentral DeFuria J, Belkina AC, Jagannathan-Bogdan M, Snyder-Cappione J, Carr JD, Nersesova YR, et al. B cells promote inflammation in obesity and type 2 diabetes through regulation of T-cell function and an inflammatory cytokine profile. Proc Natl Acad Sci U S A. 2013;110(13):5133–8.CrossRefPubMedPubMedCentral
8.
Zurück zum Zitat Igoillo-Esteve M, Marselli L, Cunha DA, Ladriere L, Ortis F, Grieco FA, et al. Palmitate induces a pro-inflammatory response in human pancreatic islets that mimics CCL2 expression by beta cells in type 2 diabetes. Diabetologia. 2010;53(7):1395–405.CrossRefPubMed Igoillo-Esteve M, Marselli L, Cunha DA, Ladriere L, Ortis F, Grieco FA, et al. Palmitate induces a pro-inflammatory response in human pancreatic islets that mimics CCL2 expression by beta cells in type 2 diabetes. Diabetologia. 2010;53(7):1395–405.CrossRefPubMed
9.
Zurück zum Zitat Sobngwi E, Mauvais-Jarvis F, Vexiau P, Mbanya JC, Gautier JF. Diabetes in Africans. Part 2: ketosis-prone atypical diabetes mellitus. Diabetes Metab. 2002;28(1):5–12.PubMed Sobngwi E, Mauvais-Jarvis F, Vexiau P, Mbanya JC, Gautier JF. Diabetes in Africans. Part 2: ketosis-prone atypical diabetes mellitus. Diabetes Metab. 2002;28(1):5–12.PubMed
10.
Zurück zum Zitat Sobngwi E, Gautier JF. Adult-onset idiopathic type I or ketosis-prone type II diabetes: evidence to revisit diabetes classification. Diabetologia. 2002;45(2):283–5.CrossRefPubMed Sobngwi E, Gautier JF. Adult-onset idiopathic type I or ketosis-prone type II diabetes: evidence to revisit diabetes classification. Diabetologia. 2002;45(2):283–5.CrossRefPubMed
11.
Zurück zum Zitat Choukem SP, Sobngwi E, Fetita LS, Boudou P, De Kerviler E, Boirie Y, et al. Multitissue insulin resistance despite near-normoglycemic remission in Africans with ketosis-prone diabetes. Diabetes Care. 2008;31(12):2332–7.CrossRefPubMedPubMedCentral Choukem SP, Sobngwi E, Fetita LS, Boudou P, De Kerviler E, Boirie Y, et al. Multitissue insulin resistance despite near-normoglycemic remission in Africans with ketosis-prone diabetes. Diabetes Care. 2008;31(12):2332–7.CrossRefPubMedPubMedCentral
12.
Zurück zum Zitat Choukem SP, Sobngwi E, Boudou P, Fetita LS, Porcher R, Ibrahim F, et al. Beta- and alpha-cell dysfunctions in africans with ketosis-prone atypical diabetes during near-normoglycemic remission. Diabetes Care. 2013;36(1):118–23.CrossRefPubMed Choukem SP, Sobngwi E, Boudou P, Fetita LS, Porcher R, Ibrahim F, et al. Beta- and alpha-cell dysfunctions in africans with ketosis-prone atypical diabetes during near-normoglycemic remission. Diabetes Care. 2013;36(1):118–23.CrossRefPubMed
13.
Zurück zum Zitat Mauvais-Jarvis F, Sobngwi E, Porcher R, Riveline JP, Kevorkian JP, Vaisse C, et al. Ketosis-prone type 2 diabetes in patients of sub-Saharan African origin: clinical pathophysiology and natural history of beta-cell dysfunction and insulin resistance. Diabetes. 2004;53(3):645–53.CrossRefPubMed Mauvais-Jarvis F, Sobngwi E, Porcher R, Riveline JP, Kevorkian JP, Vaisse C, et al. Ketosis-prone type 2 diabetes in patients of sub-Saharan African origin: clinical pathophysiology and natural history of beta-cell dysfunction and insulin resistance. Diabetes. 2004;53(3):645–53.CrossRefPubMed
14.
Zurück zum Zitat Concha LL, Durruty AP, Garcia de Los Rios AM. Ketosis prone type 2 diabetes (KPD). Rev Med Chil. 2015;143(9):1215–8.CrossRef Concha LL, Durruty AP, Garcia de Los Rios AM. Ketosis prone type 2 diabetes (KPD). Rev Med Chil. 2015;143(9):1215–8.CrossRef
15.
16.
Zurück zum Zitat Balti EV, Ngo-Nemb MC, Lontchi-Yimagou E, Atogho-Tiedeu B, Effoe VS, Akwo EA, et al. Association of HLA class II markers with autoantibody-negative ketosis-prone atypical diabetes compared to type 2 diabetes in a population of sub-Saharan African patients. Diabetes Res Clin Pract. 2015;107(1):31–6.CrossRefPubMed Balti EV, Ngo-Nemb MC, Lontchi-Yimagou E, Atogho-Tiedeu B, Effoe VS, Akwo EA, et al. Association of HLA class II markers with autoantibody-negative ketosis-prone atypical diabetes compared to type 2 diabetes in a population of sub-Saharan African patients. Diabetes Res Clin Pract. 2015;107(1):31–6.CrossRefPubMed
17.
Zurück zum Zitat Mauvais-Jarvis F, Boudou P, Sobngwi E, Riveline JP, Kevorkian JP, Villette JM, et al. The polymorphism Gly574Ser in the transcription factor HNF-1alpha is not a marker of adult-onset ketosis-prone atypical diabetes in afro-Caribbean patients. Diabetologia. 2003;46(5):728–9.CrossRefPubMed Mauvais-Jarvis F, Boudou P, Sobngwi E, Riveline JP, Kevorkian JP, Villette JM, et al. The polymorphism Gly574Ser in the transcription factor HNF-1alpha is not a marker of adult-onset ketosis-prone atypical diabetes in afro-Caribbean patients. Diabetologia. 2003;46(5):728–9.CrossRefPubMed
18.
Zurück zum Zitat Mauvais-Jarvis F, Smith SB, Le May C, Leal SM, Gautier JF, Molokhia M, et al. PAX4 gene variations predispose to ketosis-prone diabetes. Hum Mol Genet. 2004;13(24):3151–9.CrossRefPubMed Mauvais-Jarvis F, Smith SB, Le May C, Leal SM, Gautier JF, Molokhia M, et al. PAX4 gene variations predispose to ketosis-prone diabetes. Hum Mol Genet. 2004;13(24):3151–9.CrossRefPubMed
19.
Zurück zum Zitat Sobngwi E, Gautier JF, Kevorkian JP, Villette JM, Riveline JP, Zhang S, et al. High prevalence of glucose-6-phosphate dehydrogenase deficiency without gene mutation suggests a novel genetic mechanism predisposing to ketosis-prone diabetes. J Clin Endocrinol Metab. 2005;90(8):4446–51.CrossRefPubMed Sobngwi E, Gautier JF, Kevorkian JP, Villette JM, Riveline JP, Zhang S, et al. High prevalence of glucose-6-phosphate dehydrogenase deficiency without gene mutation suggests a novel genetic mechanism predisposing to ketosis-prone diabetes. J Clin Endocrinol Metab. 2005;90(8):4446–51.CrossRefPubMed
20.
Zurück zum Zitat Umpierrez GE, Woo W, Hagopian WA, Isaacs SD, Palmer JP, Gaur LK, et al. Immunogenetic analysis suggests different pathogenesis for obese and lean African-Americans with diabetic ketoacidosis. Diabetes Care. 1999;22(9):1517–23.CrossRefPubMed Umpierrez GE, Woo W, Hagopian WA, Isaacs SD, Palmer JP, Gaur LK, et al. Immunogenetic analysis suggests different pathogenesis for obese and lean African-Americans with diabetic ketoacidosis. Diabetes Care. 1999;22(9):1517–23.CrossRefPubMed
21.
Zurück zum Zitat Sobngwi E, Choukem SP, Agbalika F, Blondeau B, Fetita LS, Lebbe C, et al. Ketosis-prone type 2 diabetes mellitus and human herpesvirus 8 infection in sub-saharan africans. JAMA. 2008;299(23):2770–6.CrossRefPubMed Sobngwi E, Choukem SP, Agbalika F, Blondeau B, Fetita LS, Lebbe C, et al. Ketosis-prone type 2 diabetes mellitus and human herpesvirus 8 infection in sub-saharan africans. JAMA. 2008;299(23):2770–6.CrossRefPubMed
22.
Zurück zum Zitat Brooks-Worrell BM, Iyer D, Coraza I, Hampe CS, Nalini R, Ozer K, et al. Islet-specific T-cell responses and proinflammatory monocytes define subtypes of autoantibody-negative ketosis-prone diabetes. Diabetes Care. 2013;36(12):4098–103.CrossRefPubMedPubMedCentral Brooks-Worrell BM, Iyer D, Coraza I, Hampe CS, Nalini R, Ozer K, et al. Islet-specific T-cell responses and proinflammatory monocytes define subtypes of autoantibody-negative ketosis-prone diabetes. Diabetes Care. 2013;36(12):4098–103.CrossRefPubMedPubMedCentral
23.
Zurück zum Zitat Lontchi-Yimagou E, Nguewa JL, Assah F, Noubiap JJ, Boudou P, Djahmeni E, et al. Ketosis-prone atypical diabetes in Cameroonian people with hyperglycaemic crisis: frequency, clinical and metabolic phenotypes. Diabet Med. 2017;34(3):426–31.CrossRefPubMed Lontchi-Yimagou E, Nguewa JL, Assah F, Noubiap JJ, Boudou P, Djahmeni E, et al. Ketosis-prone atypical diabetes in Cameroonian people with hyperglycaemic crisis: frequency, clinical and metabolic phenotypes. Diabet Med. 2017;34(3):426–31.CrossRefPubMed
24.
Zurück zum Zitat Lontchi-Yimagou E, Nguewa JL, Assah F, Noubiap JJ, Boudou P, Djahmeni E, et al., Ketosis-prone atypical diabetes in Cameroonian people with hyperglycaemic crisis: frequency, clinical and metabolic phenotypes. Diabet Med 2016. Lontchi-Yimagou E, Nguewa JL, Assah F, Noubiap JJ, Boudou P, Djahmeni E, et al., Ketosis-prone atypical diabetes in Cameroonian people with hyperglycaemic crisis: frequency, clinical and metabolic phenotypes. Diabet Med 2016.
25.
Zurück zum Zitat Roy MS, Janal MN, Crosby J, Donnelly R. Inflammatory biomarkers and progression of diabetic retinopathy in African Americans with type 1 diabetes. Invest Ophthalmol Vis Sci. 2013;54(8):5471–80.CrossRefPubMedPubMedCentral Roy MS, Janal MN, Crosby J, Donnelly R. Inflammatory biomarkers and progression of diabetic retinopathy in African Americans with type 1 diabetes. Invest Ophthalmol Vis Sci. 2013;54(8):5471–80.CrossRefPubMedPubMedCentral
26.
Zurück zum Zitat Imai Y, Dobrian AD, Weaver JR, Butcher MJ, Cole BK, Galkina EV, et al. Interaction between cytokines and inflammatory cells in islet dysfunction, insulin resistance and vascular disease. Diabetes Obes Metab. 2013;15(Suppl 3):117–29.CrossRefPubMedPubMedCentral Imai Y, Dobrian AD, Weaver JR, Butcher MJ, Cole BK, Galkina EV, et al. Interaction between cytokines and inflammatory cells in islet dysfunction, insulin resistance and vascular disease. Diabetes Obes Metab. 2013;15(Suppl 3):117–29.CrossRefPubMedPubMedCentral
27.
Zurück zum Zitat Butcher MJ, Hallinger D, Garcia E, Machida Y, Chakrabarti S, Nadler J, et al. Association of proinflammatory cytokines and islet resident leucocytes with islet dysfunction in type 2 diabetes. Diabetologia. 2014;57(3):491–501.CrossRefPubMedPubMedCentral Butcher MJ, Hallinger D, Garcia E, Machida Y, Chakrabarti S, Nadler J, et al. Association of proinflammatory cytokines and islet resident leucocytes with islet dysfunction in type 2 diabetes. Diabetologia. 2014;57(3):491–501.CrossRefPubMedPubMedCentral
28.
Zurück zum Zitat Maedler K, Sergeev P, Ris F, Oberholzer J, Joller-Jemelka HI, Spinas GA, et al. Glucose-induced beta cell production of IL-1beta contributes to glucotoxicity in human pancreatic islets. J Clin Invest. 2002;110(6):851–60.CrossRefPubMedPubMedCentral Maedler K, Sergeev P, Ris F, Oberholzer J, Joller-Jemelka HI, Spinas GA, et al. Glucose-induced beta cell production of IL-1beta contributes to glucotoxicity in human pancreatic islets. J Clin Invest. 2002;110(6):851–60.CrossRefPubMedPubMedCentral
29.
Zurück zum Zitat Robertson RP, Harmon J, Tran PO, Poitout V. Beta-cell glucose toxicity, lipotoxicity, and chronic oxidative stress in type 2 diabetes. Diabetes. 2004;53(Suppl 1):S119–24.CrossRefPubMed Robertson RP, Harmon J, Tran PO, Poitout V. Beta-cell glucose toxicity, lipotoxicity, and chronic oxidative stress in type 2 diabetes. Diabetes. 2004;53(Suppl 1):S119–24.CrossRefPubMed
30.
Zurück zum Zitat Stentz FB, Umpierrez GE, Cuervo R, Kitabchi AE. Proinflammatory cytokines, markers of cardiovascular risks, oxidative stress, and lipid peroxidation in patients with hyperglycemic crises. Diabetes. 2004;53(8):2079–86.CrossRefPubMed Stentz FB, Umpierrez GE, Cuervo R, Kitabchi AE. Proinflammatory cytokines, markers of cardiovascular risks, oxidative stress, and lipid peroxidation in patients with hyperglycemic crises. Diabetes. 2004;53(8):2079–86.CrossRefPubMed
31.
Zurück zum Zitat Chen S, de Craen AJ, Raz Y, Derhovanessian E, Vossen AC, Westendorp RG, et al. Cytomegalovirus seropositivity is associated with glucose regulation in the oldest old. Results from the Leiden 85-plus study. Immun Ageing. 2012;9(1):18.CrossRefPubMedPubMedCentral Chen S, de Craen AJ, Raz Y, Derhovanessian E, Vossen AC, Westendorp RG, et al. Cytomegalovirus seropositivity is associated with glucose regulation in the oldest old. Results from the Leiden 85-plus study. Immun Ageing. 2012;9(1):18.CrossRefPubMedPubMedCentral
Metadaten
Titel
Acute phase ketosis-prone atypical diabetes is associated with a pro-inflammatory profile: a case-control study in a sub-Saharan African population
verfasst von
Eric Lontchi-Yimagou
Philippe Boudou
Jean Louis Nguewa
Jean Jacques Noubiap
Vicky Kamwa
Eric Noel Djahmeni
Babara Atogho-Tiedeu
Marcel Azabji-Kenfack
Martine Etoa
Gaelle Lemdjo
Mesmin Yefou Dehayem
Jean Claude Mbanya
Jean-Francois Gautier
Eugène Sobngwi
Publikationsdatum
29.03.2018
Verlag
Springer International Publishing
Erschienen in
Journal of Diabetes & Metabolic Disorders / Ausgabe 1/2018
Elektronische ISSN: 2251-6581
DOI
https://doi.org/10.1007/s40200-018-0336-8

Weitere Artikel der Ausgabe 1/2018

Journal of Diabetes & Metabolic Disorders 1/2018 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.